PolyPid Ltd. (PYPD)
5.10
+0.12
(+2.31%)
USD |
NASDAQ |
Aug 25, 16:00
4.57
-0.53
(-10.39%)
After-Hours: 06:04
PolyPid EPS Diluted (Quarterly) : -0.3467 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3467 |
| March 31, 2026 | -0.3525 |
| December 31, 2025 | -0.4115 |
| September 30, 2025 | -0.3715 |
| June 30, 2025 | -0.7769 |
| March 31, 2025 | -0.7036 |
| December 31, 2024 | -1.13 |
| September 30, 2024 | -1.220 |
| June 30, 2024 | -1.253 |
| March 31, 2024 | -1.374 |
| December 31, 2023 | -3.844 |
| September 30, 2023 | -3.396 |
| June 30, 2023 | -0.1315 |
| March 31, 2023 | -0.2823 |
| December 31, 2022 | -0.3324 |
| September 30, 2022 | -0.4731 |
| June 30, 2022 | -0.6073 |
| March 31, 2022 | -0.627 |
| December 31, 2021 | -0.7055 |
| September 30, 2021 | -0.5297 |
| June 30, 2021 | -0.5588 |
| March 31, 2021 | -0.4665 |
| December 31, 2020 | -0.4082 |
| September 30, 2020 | -0.3507 |
| June 30, 2020 | -25.30 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5882 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.1237 |
| June 30, 2019 | 0.0172 |
| March 31, 2019 | -0.1907 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
| Purple Biotech Ltd. | 0.4069 |
| Sol-Gel Technologies Ltd. | -1.126 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.849M |
| Total Expenses (Quarterly) | 7.849M |
| Enterprise Value | 98.39M |
| Earnings Yield | -29.06% |
| Normalized Earnings Yield | -29.06 |